SCHEMBL4629591

SCHEMBL4629591

CCCCC[CH]c1cc[nH]n1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 1/20 0.31
TSHR P16473 2/20 0.30
LTA4H P09960 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4629495 0.94 CYP1A2 (0.30)
SCHEMBL14911108 0.74 CAPN1 (0.34)
SCHEMBL16869542 0.72 TYMP (0.34)
SCHEMBL11191548 0.71 GPR84 (0.30)
SCHEMBL9428445 0.70 MGLL (0.31) TSHR
Dodecane SCHEMBL28106124 0.68 HTT (0.36) TSHR
SCHEMBL12468222 0.68 CAPN1 (0.35)
SCHEMBL4702245 0.67
SCHEMBL18272457 0.67
SCHEMBL6476566 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919907-A2 HETEROCYCLIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-05-14 EP disclosed
WO-2007026959-A2 DERIVATIVES OF 4-PIPERAZIN-1-YL-4-BENZ0 [B] THIOPHENE SUITABLE FOR THE TREATMENT OF CNS DISORDERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-03-08 WO disclosed